Recent advances of serodiagnosis for systemic fungal infections

Japanese Journal of Medical Mycology

Volumn 47, Issue 3, 2006, Pages 135-142

  Yoshida, Koichiro ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

1 3 D 1 3 D glucan; Aspergillosis; Galactomannann antigen; Non specific reaction; Serological surrogate diagnostic marker

Indexed keywords

GALACTOMANNAN; PIPERACILLIN PLUS TAZOBACTAM;

ANTIGEN DETECTION; ASPERGILLUS FUMIGATUS; BIFIDOBACTERIUM; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; JAPAN; MYCOSIS; PENICILLIUM; REVIEW; SERODIAGNOSIS;

ASPERGILLOSIS; BETA-GLUCANS; HUMANS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

ASPERGILLUS; ASPERGILLUS GALACTOMANNAN;

EID: 33748478599     PISSN: 09164804     EISSN: 09164804     Source Type: Journal    
DOI: 10.3314/jjmm.47.135     Document Type: Review

References (27)

1. Mora-Duarte J, Betts R, Rotstein C, Colombo AL, Thompson-Moya L, Smietana J, Lupinacci R, Sable C, Kartsonis N, Perfect J: Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 347: 2020-2029, 2002.
2. Herbrecht R, Denning DW, Patterson TF, Bennet JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortholary O, Sylvester R, Rubin RH, Wingard JR, Stark P, Durand C, Caillot D, Thiel E, Chandrasekar PH, Hodges MR, Schlamm HT, Troke PF, DePauw B: Voriconazol versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347: 408-415, 2002.
3. Mennink-Kersten MASH, Donnelly JP, Verweij PE: Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 4: 349-357, 2004.
4. Ulusakarya A, Chachaty E, Vantelon JM, Youssef A, Tancre -de C, Pico JL, Bourhis JH, Fenaux P, Munck JN: Surveillance of Aspergillus galactomannan antigenemia for invasive aspergillosis by enzyme-linked immunosorbent assay in neutropenic patients treated for hematological malignancies. Hematol J 1: 111-116, 2000.
5. Kawazu M, Kanda Y, Nannya Y, Aoki K, Kurokawa M, Chiba S, Motokura T, Hirai H, Ogawa S: Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and (1→3)-β-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders. J Clin Microbiol 42: 2733-2741, 2004.
6. Marr KA, Balajee SA, McLaughlin L, Tabouret M, Bentsen C, Walsh TJ: Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis 190: 641-649, 2004.
7. Viscoli C, Machetti M, Cappellano P, Bucci B, Bruzzi P, Lint MTV, Bacigalupo A: False-positive galactomannan Platelia Aspergillus test results for patients receiving piperacillin- tazobactam. Clin Infect Dis 38: 913-916, 2004.
8. Adam O, Aupérin A, Wilquin F, Bourhis JH, Gachot B, Chachaty E: Treatment with piperacillin) tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies. Clin Infect Dis 38: 917-920, 2004.
9. Singh N, Obman A, Husain S, Aspinall S, Mietzner S, Stout JE: Reactivity of Platelia Aspergillus galactomannan antigen with piperacillin) tazobactam: clinical implications based on achievable concentration in serum. Antimicrob Agent Chemother 48: 1989-1992, 2004.
10. Dalle F, Charles PE, Blanc K, Caillot D, Chavanet P, Dromer F, Bonnin A: Cryptococcus neoformance galactoxylomannan contains an epitope-s) that is cross-reactive with Aspergillus galactomannan. J Clin Microbiol 43: 2929-2931, 2005.
11. Mennink-Kersten MASH, Roegebrink D, Klont RR, Warris A, Gavini F, Op den Camp HJM, Verweij PE: Bifidobacterial lipogrycan as a new cause for false-positive Platelia Aspergillus enzeme-linked immunosorbent assay reactivity. J Clin Microbiol 43: 3925-3931, 2005.
12. Herbrecht R, Letscher-Bru V, Oprea C, Lioure B, Waller J, Campos F, Villard O, Lis KL, Natarajan-Amé S, Lutz P, Dufour P, Bergerat JP, Candolfi E: Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol 20: 1898-1906, 2005.
13. Gangneux JP, Lavarde D, Bretagne S, et al: Transient Aspergillus antigenimea: think of milk. Lancet 359: 1251, 2002.
14. Marr KA, Laverdiere M, Gugel A, Leisenring W: Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis 40: 1762-1769, 2005.
15. Weig M, Frosch M, Tintelnot K, Haas A, Groß U, Linsmeier B, Heesemann J: Use of recombinant mitogillin for improved serodiagnosis of Aspergillus fumigatus-assosiated diseases. J Clin Microbiol 39: 1721-1730, 2001.
16. Chan C, Woo PCY, Leung ASP, Lau SKP, Che X, Cao L, Yuen K: Detection of antibodies specific to an antigenic cell wall galactomannoprotein for serodiagnosis of Aspergillus fumigatus aspergillosis. J Clin Microbiol 40: 2041-2045, 2002.
17. Woo PCY, Chan C, Leung ASP, Lau SKP, Che X, Wong SSY, Cao L, Yuen K: Detection of cell wall galactomannoprotein Afmp1p in culture supernatants of Aspergillus fumigatus and in sera of aspergillosis patients. J Clin Microbiol 40: 4382-4387, 2002.
18. Odabasi Z, Mattiuzzi G, Estey E, Kantarjian H, Saeki F, Ridge RJ, Ketchum PA, Finkelman MA, Rex JH, Ostrosky-Zeichner L: β-D-glucan as diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis. 39: 199-205, 2004.
19. Pazos C, Ponton J, Paracio AD: Contribution of (1→3)-β-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol 43: 299-305, 2005.